^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

KDR rs1870377

i
Other names: KDR, CD309, FLK1, VEGFR, VEGFR2, Kinase insert domain receptor (a type III receptor tyrosine kinase)
Entrez ID:
Related biomarkers:
7ms
A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Topical Urea for Secondary Prophylaxis of Hand Foot Skin Reaction in Renal Cell Cancer Patients on Sunitinib Therapy. (PubMed, Clin Genitourin Cancer)
The study suggested that the urea-based cream was not superior to placebo in decreasing the appearance of new HFSR in renal cancer patients receiving 4:2 regimen of sunitinib.
Clinical • Journal
|
KDR (Kinase insert domain receptor)
|
KDR rs1870377
|
sunitinib
1year
Journal
|
KDR (Kinase insert domain receptor)
|
KDR rs1870377